 WESTLAKE VILLAGE, Calif., Sept. 28, 2021 GLOBE NEWSWIRE -- MannKind Corporation Nasdaq: MNKD, a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that it will be participating at the Lytham Partners Fall 2021 Investor Conference on Tuesday, October 5, 2021 at 11:45 am ET. Presenting from the Company will be its Chief Executive Officer, Michael Castagna, PharmD. 